Association between Body Mass Index, Lipid Profiles, and Types of Urinary Stones

REFERENCES

• Pak CY. Kidney stones. Lancet. 1998;351:1797–1801.
   PubMed Web of Science ®Google Scholar
• Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management? Kidney Int. 2005;68:1808–1814.
   PubMed Web of Science ®Google Scholar
• Daudon M, Jungers P. Drug-induced renal calculi: Epidemiology, prevention and management. Drugs. 2004;64: 245–275.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–838.
   PubMed Web of Science ®Google Scholar
• Kaul P, Sidhu H, Sharma SK, Nath R. Calculogenic potential of galactose and fructose in relation to urinary excretion of lithogenic substances in vitamin B6 deficient and control rats. J Am Coll Nutr. 1996;15:295–302.
   PubMed Web of Science ®Google Scholar
• Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59: 270–276.
   PubMed Web of Science ®Google Scholar
• Saldana TM, Basso O, Darden R, Sandler DP. Carbonated beverages and chronic kidney disease. Epidemiology. 2007;18: 501–506.
   PubMedGoogle Scholar
• Hammarsten J, Peeker R. Urological aspects of the metabolic syndrome. Nat Rev Urol. 2011;8:483–494.
   PubMedGoogle Scholar
• Gorbachinsky I, Akpinar H, Assimos DG. Metabolic syndrome and urologic diseases. Rev Urol. 2011;12(Fall):e157–e180.
   Google Scholar
• Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int. 2009;75:585–595.
   PubMedGoogle Scholar
• Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. J Am Med Assoc. 2002;288:1723–1727.
   PubMed Web of Science ®Google Scholar
• Kopelman PG. Obesity as a medical problem. Nature. 2000;404: 635–643.
   PubMed Web of Science ®Google Scholar
• Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol. 2005;12:859–863.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Am Med Assoc. 2005;293:455–462.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Am Soc Nephrol. 1998;9: 1645–1652.
   PubMed Web of Science ®Google Scholar
• Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002;62:971–979.
   PubMed Web of Science ®Google Scholar
• Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 2006;17:1422–1428.
   PubMed Web of Science ®Google Scholar
• Pak CY, Sakhaee K, Moe O, . Biochemical profile of stone-forming patients with diabetes mellitus. Urology. 2003;61: 523–527.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–1235.
   PubMed Web of Science ®Google Scholar
• Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant. 2011;26:864–868.
   PubMedGoogle Scholar
• Rendina D, Mossetti G, De Filippo G, . Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: Role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant. 2009;24:900–906.
   PubMedGoogle Scholar
• Cappuccio FP, Siani A, Barba G, . A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens. 1999;17:1017–1022.
   PubMed Web of Science ®Google Scholar
• Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: A review. Am J Hypertens. 2008;21:257–264.
   PubMed Web of Science ®Google Scholar
• Diagnosis and classification of diabetes mellitus. Diabetes Care. 34(Suppl. 1):S62–S69.
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, . Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42: 1206–1252.
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Dretler SP. Ureteral stone disease. Options for management. Urol Clin North Am. 1990;17:217–230.
   PubMed Web of Science ®Google Scholar
• Smith CL. Renal stone analysis: Is there any clinical value? Curr Opin Nephrol Hypertens. 1998;7:703–709.
   PubMedGoogle Scholar
• Daudon M, Jungers P. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Nephron Physiol. 2004;98:31–36.
   Google Scholar
• Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111:1006–1009.
   PubMed Web of Science ®Google Scholar
• Li WM, Chou YH, Li CC, . Association of body mass index and urine pH in patients with urolithiasis. Urol Res. 2009;37: 193–196.
   PubMed Web of Science ®Google Scholar
• Ekeruo WO, Tan YH, Young MD, . Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004;172:159–163.
   PubMedGoogle Scholar
• Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–915.
   PubMed Web of Science ®Google Scholar
• Siener R, Glatz S, Nicolay C, Hesse A. The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004;12:106–113.
   PubMedGoogle Scholar
• Taylor EN, Mount DB, Forman JP, Curhan GC. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis. 2006;47: 780–789.
   PubMedGoogle Scholar
• Grases F, Sanchis P, Perello J, Costa-Bauza A. Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol. 2006;13:252–256.
   PubMed Web of Science ®Google Scholar
• Grover PK, Ryall RL. Critical appraisal of salting-out and its implications for chemical and biological sciences. Chem Rev. 2005;105:1–10.
   PubMed Web of Science ®Google Scholar
• Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol. 2008;28:174–180.
   PubMedGoogle Scholar
• Chou YH, Su CM, Li CC, . Difference in urinary stone components between obese and non-obese patients. Urol Res. 2010;39:283–287.
   PubMedGoogle Scholar
• Kajikawa H. The influence of dietary lipids on nephrolithiasis in rats. Nippon Hinyokika Gakkai Zasshi. 1998;89:931–938.
   PubMedGoogle Scholar
• Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A. Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol. 2008;180: 2212–2217.
   PubMedGoogle Scholar
• Iba A, Kohjimoto Y, Mori T, . Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome. BJU Int. 2010;106:1550–1554.
   PubMedGoogle Scholar